A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...
Bayer announced today the initiation of a global Phase II clinical trial (NCT07625215) evaluating BAY 3670549, an investigational highly selective G-protein-coupled inwardly rectifying potassium ...
Background: Several clinical factors have been studied to predict atrial fibrillation (AF) recurrence after electrical cardioversion (ECV) with limited predictive value. Methods: A method able to ...
Moderate coffee consumption may reduce AF recurrence risk post-cardioversion, contradicting traditional advice to avoid caffeine. The DECAF trial showed a 39% lower recurrence risk in coffee drinkers ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
Bayer begins phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation: Berlin Thursday, September 10, 2026, 10:00 Hrs [IST] Bayer announced the initi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results